MoneyWorks4Me

The company witnessed a 10.38% growth in the revenue at Rs. 633.42 millions for the quarter ended December 2023 as compared to Rs. 573.83 millions during the year-ago period.Profit for the quarter ended December 2023 rises by 54.91% to Rs. 64.21  millions from Rs. 41.45 millions.OP of the company witnessed a marginal growth to 111.49 millions from 78.84 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 633.42 573.83 10.38 1850.93 1632.74 13.36 2246.44 2196.63 2.27
Other Income 43.49 19.78 119.87 102.30 78.30 30.65 146.10 119.93 21.82
PBIDT 111.49 78.84 41.41 292.80 215.12 36.11 342.22 320.28 6.85
Interest 10.82 7.17 50.91 32.80 18.39 78.36 31.30 19.28 62.34
PBDT 100.43 71.67 40.13 259.76 196.73 32.04 311.05 301.24 3.26
Depreciation 14.46 12.02 20.30 34.25 33.72 1.57 45.39 39.48 14.97
PBT 85.97 59.65 44.12 225.51 163.01 38.34 265.66 261.76 1.49
TAX 21.76 18.20 19.56 56.76 46.91 21.00 64.96 63.86 1.72
Deferred Tax 0.98 2.10 -53.33 5.11 6.31 -19.02 -1.53 1.40 -209.29
PAT 64.21 41.45 54.91 168.75 116.10 45.35 200.70 197.90 1.41
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 862.45 8.99
PBIDTM(%) 17.60 13.74 28.11 15.82 13.18 20.07 15.23 14.58 4.48
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..